Almost 2,500 years ago, Hippocrates stated that "All disease begin in the gut." Ivan Pavlov, the Russian physiologist and father of modern gastroenterology (GI) research, recognized that "The digestive canal represents a tube passing through the entire organism and communicating with the external world, i.e., as it were the external surface of the body, but turned inwards and thus hidden in the organism" (Nobel Lecture, 1904) . His research emphasized the complexity of regulating gut motility and its importance in digestion. However, he also keenly understood that the GI tract communicated with the external world, which presaged the exploration of symbiotic relationships between microbes that invade and colonize the GI tract and we humans as their hosts. In this issue of Physiology, we explore the GI tract and other tubes in our body that mediate movement of nutrients, blood, and air to sustain life, yet, when dysfunctional, so profoundly affect our health.
Interstitial cells regulate the motor activity of the GI tract by providing pacemaker activity and by mediating inputs from motoneurons as well as responsiveness to stretch. GI motility is important for expansion of gastric volume during the ingestion of food, opening and closing of sphincters between organs, facilitating gastric emptying, providing proper mixing and absorption of nutrients in the intestine, providing the means for recovery of water and electrolytes in the colon, and permitting orderly removal of wastes through defecation. In their review (5), Sanders and colleagues explore how the interstitial cell population is altered in many GI motility disorders experienced by humans and whether loss or defects in these cells can contribute to paralysis or ineffective movements, causing retention or too hasty movement of nutrients and wastes. Understanding the mechanisms involved in interstitial cell function and why this population of cells is vulnerable in various diseases may provide methods to prevent loss or dysfunction of these important regulatory cells and provide better quality of life or prevent loss of life in patients.
Obesity is a growing epidemic that brings with it many associated complications including cardiovascular disease and Type 2 diabetes mellitus, which place an ever increasing burden on healthcare. Obesity results from a complex interaction of genetic, environmental, cultural, behavioral, and microbial factors. The gut microbiome is a diverse array of microorganisms that colonize our GI tract. In recent years, we have increased our understanding of the delicate symbiosis that exists between the trillions of microbes that reside in the GI tract and humans as hosts. It has been suggested that disruption of this mutual tolerance may play a significant role in modulating host physiology during obesity. In their review (4), Nehra and colleagues explore environmental and lifestyle influences such as diet, exercise, and early life exposures that can significantly impact the composition of the gut microbiome. They emphasize that any resulting microbial imbalance or dysbiosis can lead to increased host adiposity via a number of different mechanisms. For example, it appears that microbiota have the ability to regulate host fat deposition, metabolism, and immune function. Thus characterization of the gut microbiome in health and disease should eventually lead toward early diagnosis, better prognostication, and intentional modulation of the composition of the microbiome in favor of disease prevention. Based on different microbial composition, there is potential for development of specific biomarkers to identify individuals at risk for development of obesity and stratification to personalized treatment options including diet, lifestyle modifications, pre-probiotics, or bariatric surgery.
Insulin resistance refers to decreased metabolic action of insulin and is a defining feature of Type 2 diabetes. Although impairment of insulin signaling in skeletal muscle and other organs is well understood, the mechanisms of insulin delivery are not. Insulin delivery consists of two stages: 1) perfusion of tissues and 2) the transendothelial movement of insulin from the blood stream (insulin transcytosis). The physiology of the second stagetranscytosis-has been technically difficult to study. In their review (3), Lee and Klip consider the mechanisms of insulin transcytosis and its contribution to insulin resistance. Importantly, although insulin delivery is known to be impaired in obesity and diabetes, it is unclear whether insulin transit across the endothelium per se is altered. Further research of insulin transcytosis should increase our knowledge of the pathogenesis of insulin resistance. If the passage of insulin out of the circulation contributes to whole-body insulin resistance, enhancement of this process may lead to a novel therapeutic approach for patients with Type 2 diabetes, a disease that afflicts hundreds of millions of people.
Cells in the body are exposed to irregular physiological forces, such as touch, movement, gravity, blood flow, blood pressure, and breathing. For example, blood pressure exerts a physiological force on the vascular wall that displays beat-to-beat variability. Similarly, changes in pressure across the thoracic wall and lungs move air into and out of the lung, with natural physiological variability of mechanical forces. The irregularity of mechanical stimuli significantly influences many basic cell functions, yet studies exploring mechanotransduction (mechanical forceinduced cellular processes) invariably investigate only monotonous stretch. In their review (6), Suki and colleagues discuss how fluctuations in mechanical stimuli regulate mechanotransduction, called fluctuation-driven mechanotransduction (FDM). The two main FDM mechanisms are an increase in cellular ATP production as a result of mechanical fluctuations, and structural reorganization of the cytoskeleton with selective activation of signal transduction pathways. These processes have significant implications for human health. Hypertension is accompanied by increased blood pressure variability, an independent risk predictor of cardiovascular morbidity, with consequences on vascular smooth muscle contractility. Since FDM also regulates surfactant metabolism in the lung, artificial elimination of breath-to-breath tidal volume variability during mechanical ventilation may directly affect patient care. Finally, everyday physical activity likely generates blood pressure and breathing variabilities that are important for cellular metabolism in health, whereas therapeutic activity during rehabilitation may help restore normal cell function in diseases.
Fluid shear stress, the force that flowing blood exerts on the endothelial cells of vessel walls, is a major determinant of vascular development, physiology, and disease. Shear stresses, which vary in different types of vessels and in different regions of the same vessel, have a major influence on endothelial phenotype. For example, shear stress controls vasodilation vs. vasoconstriction, vessel stabilization vs. remodeling, and arterial vs. venous identity. In their review (2), Gerhold and Schwartz discuss ion channels and their fast kinetics, sensitivity, and modulation by multiple inputs that make them candidates for the detection of shear stress and its signaling integration with other pathways. Understanding how endothelial cells detect shear stresses, how they integrate that information to control cellular responses, and how those responses contribute to blood vessel biology and pathology may lead to the development of new treatments for diseases such as hypertension, atherosclerosis, and vascular malformations.
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